The blood urea nitrogen diagnostics test is a fairly common blood test, which is used for assessing the condition of the kidneys and liver. The blood urea nitrogen diagnostics test measures the quantity of urea nitrogen in the blood. The urea nitrogen is excreted from the body through a cascade of reactions. Ammonia produced by the liver by breaking down the proteins consumed by the body cells. Nitrogen from the ammonia combines with elements such as hydrogen, carbon and oxygen that results in the formation of urea. This is a chemical waste of the body. The blood caries the urea from the liver to the kidney where it is filtered out along with other waste products to form urine that is finally excreted out from the body. Thus a blood urea nitrogen diagnostics test is used to asses if the quantity of nitrogen in the blood is higher than normal. The high value may indicate that the kidney function is hampered. Commonly the blood urea nitrogen diagnostics is conducted when the doctor suspects kidney damage, or during general kidney function evaluation. The blood urea nitrogen diagnostics is also used to determine the effectiveness of dialysis treatments such as hemodialysis or peritoneal dialysis. Other conditions such as liver damage, obstruction in the urinary tract, congestive heart failure and gastrointestinal bleeding can also be asses using the blood urea nitrogen diagnostics. However this test alone may not be able to assess the type of condition and may require confirmatory tests. For an instance, to assess and confirm kidney damage a creatinine level test is also performed along with the blood urea nitrogen diagnostics. Creatinine is also another waste product excreted out from the blood into through the urine. To assess the present kidney function glomerular filtration rate is estimated by calculating the amount of waste taken out of the blood. 7-20 mg/dL or 2.5-7.1 mmol/L is the normal concentration of urea nitrogen in the blood.
Blood Urea Nitrogen Diagnostics Market: Drivers and Restraints
Some of the factors that contribute to kidney damage and cases when a blood urea nitrogen diagnostics can be used include, old age, obstruction in urinary tract, recent heart attack or congestive heart failure, bleeding in the gastrointestine, dehydration, trauma, severe burns, adoption of a high protein diet and intake of certain antibiotics. Thus rise in the above conditions among the population crates a large pool of patients thereby driving the growth of the blood urea nitrogen diagnostics market.
Download sample copy of this report:
https://www.futuremarketinsights.com/reports/sample/REP-GB-10575
Blood Urea Nitrogen Diagnostics Market: Overview
Assay kits are the most common type of product that is used for blood urea nitrogen diagnostics. However the adoption of ELISA and other methods vary significantly across regions. This is primarily due to the price difference between the two types of technologies. Among end users hospitals and diagnostic laboratories are together expected to continue dominating the market through the forecast period.’
To View Full Table of Content (TOC): https://www.futuremarketinsights.com/toc/rep-gb-10575
Blood Urea Nitrogen Diagnostics Market: Regional Outlook
Rising incidence of cardiovascular diseases in North America, trend of regular health check, favourable reimbursement policies are some of the factors that drive the growth of the blood urea nitrogen diagnostics market in the region. However, rise in medical tourism for dialysis in APAC countries such as India support the growth of the blood urea nitrogen diagnostics market in the region, so as to have a significantly high growth rate than other regions.
Buy Now to Get 10% Off and Free Customization as per Requirement:
https://www.futuremarketinsights.com/checkout/10575
Blood Urea Nitrogen Diagnostics Market: Key Players
Some of the key players in the blood urea nitrogen diagnostics market include, Pointe Scientific, Inc., Accurex biomedical Pvt. Ltd., Invitrogen, Beacon Diagnostics Pvt. Ltd., Thermo Fisher Scientific, Eagle Biosciences, Inc., XpressBio, and Bioo Scientific Corporation, among others.